06/09/2025
3:45 PM | PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:45 PM | Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:45 PM | Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:45 PM | Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:57 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
2:20 PM | ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
3:36 PM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
3:19 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
5:06 AM | Verrica Pharmaceuticals (Filer)
| Form DEFR14A | |
04/22/2025
6:15 AM | Verrica Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2025
6:18 AM | Verrica Pharmaceuticals (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for VRCA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/22/2025
6:20 AM | Verrica Pharmaceuticals (Filer)
| Form ARS | |
04/02/2025
3:31 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
3:31 PM | Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2025
3:32 PM | Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:08 AM | Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2025
6:10 AM | Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
11:15 PM | Verrica Pharmaceuticals (Filer)
| Form EFFECT | |
03/18/2025
5:45 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:45 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:05 PM | Verrica Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/11/2025
3:23 PM | Verrica Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
4:01 PM | ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/09/2024
5:22 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/09/2024
4:17 PM | Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/09/2024
4:18 PM | Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
3:55 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/21/2024
3:53 PM | Verrica Pharmaceuticals (Filer)
| Form 424B5 | |
11/20/2024
4:06 PM | Verrica Pharmaceuticals (Filer)
| Form 424B5 | |
11/20/2024
4:08 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:32 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
7:59 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:02 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
8:03 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:04 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:11 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:17 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:15 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:37 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:15 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Gold is soaring. Here’s how to get paid from it (Ad) Gold just broke through $3,300…
And while the headlines shout about price targets, something even more powerful is happening behind the scenes…
Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge.
No trading gold futures. No mining stocks. No vaults.
Just a simple fund delivering monthly payouts — like clockwork. Click here to discover the income ETF behind it all. |
09/23/2024
3:15 PM | Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:50 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:45 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:35 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:31 PM | Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:17 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:08 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
6:56 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:07 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
5:10 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:11 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:12 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:13 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
2:51 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
2:55 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
2:47 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
